Meanwhile, regulators of apoptosis like BID and BAG1 may promote anoikis resistance, facilitating metastatic progression, a phenomenon previously described in RCC and other aggressive cancers [35,36]. The gene discussed is BID; the disease is renal cell carcinoma.